Genome-wide profiling of miRNAs identifies 388 differentially expressed miRNAs in gallbladder cancer, suggesting therapeutic targets in its pathogenesis.
Key Points
Significantly differentially expressed miRNAs target key processes like cell adhesion and apoptosis, revealing insights into gallbladder cancer.
A total of 971 known and 27 novel microRNAs were profiled, highlighting the complexity of miRNA contributions to gallbladder cancer progression.
The suppressed miR-17~92 cluster was identified as a regulator of S-phase licensing factor Cdt2, impacting cell proliferation and invasion uniquely in cancer cells.
Profiling presents opportunities for miRNA-based diagnostics and therapies, specifically targeting the oncogenic potential of specific miRNAs.